Io Biotech, Inc.
IOBT
Revenue
0.00
0.000.00%
-Assets
111.47M
▼-16.69M▼-13.02%
3 Months ChangeLiabilities
15.20M
▲2.50M▲19.71%
3 Months ChangeFree Cash Flow
-24.94M
▼-10.11M▼-68.10%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-30
Form 8-K
ID: 0001193125-24-211080
2024-08-13
Form 10-Q
ID: 0000950170-24-096168
2024-08-13
Form 8-K
ID: 0001193125-24-199383
2024-06-11
Form 8-K
ID: 0001193125-24-159193
2024-05-14
Form 8-K
ID: 0001193125-24-137754
2024-05-14
Form 10-Q
ID: 0000950170-24-059108
2024-04-26
Form 8-K
ID: 0001193125-24-118498
2024-03-05
Form 8-K
ID: 0001193125-24-059364
2024-01-08
Form 8-K
ID: 0001193125-24-003947
2023-11-13
Form 10-Q
ID: 0000950170-23-062963